Pharmacological treatment of Tourette syndrome

被引:16
|
作者
Gilbert, Donald L. [1 ]
Jankovic, Joseph [2 ]
机构
[1] Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH 45229 USA
[2] Baylor Coll Med, Houston, TX 77030 USA
关键词
Attention deficit; Hyperactivity; Obsessive-ompulsive; Tics; Tourette; DEEP-BRAIN-STIMULATION; ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; PLACEBO-CONTROLLED TRIAL; PARENT RATING-SCALE; QUALITY-OF-LIFE; DOUBLE-BLIND; TARDIVE-DYSKINESIA; CLINICAL-TRIAL; TIC SEVERITY; CERVICAL MYELOPATHY;
D O I
10.1016/j.jocrd.2014.04.006
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Tourette syndrome (TS) is a highly heritable yet heterogeneous childhood onset disorder. The cardinal movement disorder required for diagnosis is tics. As persons with tics or TS often have obsessive/compulsiveness, inattention, hyperactivity, impulsivity, anxiety, and anger outbursts, the presence of tics should prompt clinicians to look for these other conditions. While randomized controlled trials provide valid evidence of efficacy for symptoms in isolation, implications for treatment of complex patients meeting criteria for multiple diagnoses is not always clear. In this review, the authors critically review factors influencing decisions whether and how to treat medically tics as well as OCD and ADHD in the presence of tics. (C) 2014 The Authors. Published by Elsevier Inc.
引用
收藏
页码:407 / 414
页数:8
相关论文
共 50 条
  • [31] Treatment of Tourette syndrome with cannabinoids
    Mueller-Vahl, Kirsten R.
    BEHAVIOURAL NEUROLOGY, 2013, 27 (01) : 119 - 124
  • [32] Serial pharmacological prescribing practices for tic management in Tourette syndrome
    Farag, Mena
    Stern, Jeremy S.
    Simmons, Helen
    Robertson, Mary M.
    HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2015, 30 (06) : 435 - 441
  • [33] Current Approaches and New Developments in the Pharmacological Management of Tourette Syndrome
    Julio Quezada
    Keith A. Coffman
    CNS Drugs, 2018, 32 : 33 - 45
  • [34] Current Approaches and New Developments in the Pharmacological Management of Tourette Syndrome
    Quezada, Julio
    Coffman, Keith A.
    CNS DRUGS, 2018, 32 (01) : 33 - 45
  • [35] A CLINICAL PHARMACOLOGICAL APPROACH TO TREATING TOURETTE SYNDROME IN CHILDREN AND ADOLESCENTS
    KERBESHIAN, J
    BURD, L
    NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, 1988, 12 (3-4): : 241 - 245
  • [36] Treatment of Tourette's syndrome with mecamylamine
    Sanberg, PRK
    Shytle, RD
    Silver, AA
    LANCET, 1998, 352 (9129): : 705 - 706
  • [37] Treatment of tics associated with Tourette syndrome
    Joseph Jankovic
    Journal of Neural Transmission, 2020, 127 : 843 - 850
  • [38] Nicotine for the treatment of Tourette's syndrome
    Sanberg, PR
    Silver, AA
    Shytle, RD
    Philipp, MK
    Cahill, DW
    Fogelson, HM
    McConville, BJ
    PHARMACOLOGY & THERAPEUTICS, 1997, 74 (01) : 21 - 25
  • [39] Relaxation Therapy as a Treatment for Tourette Syndrome
    Tilling, Florence
    Cavanna, Andrea E.
    JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES, 2018, 30 (03) : E33 - E34
  • [40] Ziprasidone in treatment of tics in Tourette syndrome
    Blazquez-Estrada, M.
    Calatayud-Noguera, M. T.
    Blazquez-Menes, B.
    MOVEMENT DISORDERS, 2007, 22 : S282 - S282